Who we are
Mission-driven executive with a passion for the intersection between science and patient need. Serial entrepreneur with expertise building platform companies for engineered cellular medicines (in vivo and ex vivo), multispecific antibodies, diagnostics, and genomics. Founder/C-level at five startups, leading to three attractive take-out sales (acquirers - Roche, Fujifilm, Bayer), one profitable ongoing biotech (Invenra), and one early-stage venture (Ensoma). Skilled board Director with experience including Chairman of the Alliance for Regenerative Medicine, Chairman of BlueRock Therapeutics, Vice-Chairman of Invenra, and other Directorships.
https://www.linkedin.com/in/emilenuwaysir/
Education:
Ph.D. Molecular Toxicology, University of Wisconsin, Madison
Postdoctoral studies National Institute of Environmental Health Sciences National Human Genome Research Institute University of North Carolina, Chapel Hill
Emile Nuwaysir, Ph.D.
Owner and Principal